TYLER CHRISTENSEN: Open Payments
NPI 1144606146 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 86 payments from 19 companies in 2025. Trend: 2023 $791 · 2024 $1,677 · 2025 $1,716
Food & beverage: $1,631Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $362 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $350 |
| Lilly USA, LLC | 11 | $232 |
| Janssen Biotech, Inc. | 7 | $183 |
| PFIZER INC. | 11 | $182 |
| Madrigal Pharmaceuticals | 4 | $72 |
| Gilead Sciences, Inc. | 3 | $52 |
| Ardelyx, Inc. | 2 | $47 |
| Agios Pharmaceuticals, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
Products named: ENTYVIO, OMVOH, RINVOQ, TREMFYA, XELJANZ, SKYRIZI, VELSIPITY, REZDIFFRA.
Industry payments across WA — which companies pay providers there.
